Intern

Forschung / Lehre - Publikationen

Publikationen - 2013

experimentell

  • Stope M.B., Bradl J., Peters S., Streitbörger A., Weiss M., Zimmermann U., Walther R., Lillig C.H., Burchardt M. (2013) Shortened isoforms of the androgen receptor are regulated by the cytoprotective heat-shock protein HSPB1 and the tumor-suppressive microRNA miR-1 in prostate cancer cells. Anticancer Res. 33, pp. 4921-4926
  • Stope M.B., Rönnau C., Schubert T., Staar D., Bradl J., Ziegler P., Streitbörger A., Kroeger N., Zimmermann U., Walther R., Burchardt M., Börgermann C. (2013) Transforming growth factor β in prostate cancer cells: Cellular effects and basic molecular mechanisms. Urologe 52, pp. 378-383
  • Popp S.L., Joffroy C., Stope M.B., Buck M.B., Fritz P., Knabbe C. (2013) Antiestrogens suppress effects of transforming growth factor-β in breast cancer cells via the signaling axis estrogen receptor-α and Y-box binding protein-1. Anticancer Res. 33, pp. 2473-2480
  • Birkhäuser F.D., Koya R.C., Neufeld C., Rampersaud E.N., Lu X., Micewicz E.D., Chodon T., Atefi M., Kroeger N., Chandramouli G.V., Li G., Said J.W., McBride W.H., Kabbinavar F.F., Ribas A., Pantuck A.S., Riss J. (2013). Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: Efficacy, safety, and activity of Ad-GM.CAIX in immunocompetent mouse models. J. Immunother. 36, pp. 102-111

 

klinisch

  • Freeland S.J., Carducci M., Kroeger N., Partin A., Rao J.Y., Jin Y., Kerkoutian S., Wu H., Li Y., Mundy K., Gurganus R., Fedor H., King S.A., Zhang Y., Heber D., Pantuck A.J. (2013) A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy. Cancer Prev. Res. 6, pp. 1120-1127
  • Habes M., Schiller T., Rosenberg C., Burchardt M., Hoffmann W. (2013) Automated prostate segmentation in whole-body MRI scans for epidemiological studies. Phys. Med. Biol. 58, pp. 5899-5915
  • Kroeger N., Xie W., Lee J.L., Bjarnason G.A., Knox J.J., Mackenzie M.J., Wood L., Srinivas S., Vaishamayan U.N., Rha S.Y., Pal S.K., Yuasa T., Donskov F., Agarwal N., Kollmannsberger C.K., Tan M.H., North S.A., Rini B.I., Choueiri T.K., Heng D.Y. (2013) Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria. Cancer 119, pp. 2999-3006.
  • Birkhäuser F.D., Pantuck A.J., Rampersaud E.N., Wang X., Kroeger N., Pouliot F., Zomorodian N., Riss J., Li G., Kabbinavar F.F., Belldegrun A.S. (2013) Salvage-targeted kidney cancer therapy in patients progressing on high-dose interleukin-2 immunotherapy: the UCLA experience. Cancer J. 19, pp. 189-196
  • Kroeger N., Belldegrun A.S., Pantuck A.J. (2013) Pomegranate extracts in the management of men's urologic health: Scientific rationale and preclinical and clinical data. Evid. Based Complement. Alternat. Med. 2013, ID 701434.
  • Kroeger N., Klatte T., Chamie K., Rao P.N., Birkhauser F.D., Sonn G.A., Riss J., Kabbinavar F.F., Belldegrun A.S., Pantuck A.J. (2013). Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma. Cancer 119, pp. 1547-1554
  • Birkhäuser FD, Kroeger N, Pantuck AJ. Etiology of RCC: Incidence, Demographics, and Environmental Factors (2013) In: Rini BI, Campbell SC (Editors). Renal Cell Carcinoma: Clinical Management. New York: Springer Science and Business Media, pp. 3-22

 

 

 

Zurück zur Übersicht

AKTUELLES

Informationen

Links

Kontakt